Skip to content

Support with or without formula trial for infants at risk of hypoglycaemia

Support WIth or without Formula Trial for infants at risk of hypoglycaemia (SWIFT): a pilot and feasibility trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16997288
Enrollment
160
Registered
2023-01-20
Start date
2023-05-04
Completion date
Unknown
Last updated
2024-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newborn infants with risk factors for hypoglycaemia Pregnancy and Childbirth

Interventions

The SWIFT (Supplementation with or without formula trial) study is a pilot and feasibility trial, designed to compare the intended or actual use of donor human milk (DHM) where there is a medically in

Sponsors

Newcastle upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Newborn infants <24 hours of age who do not require admission for neonatal intensive care or intravenous therapy but who are at risk factors for hypoglycaemia: 1. Born at 32-36 weeks gestation 2. In-utero growth restriction (defined by unit guidelines) 3. Birthweight <2.5kg 4. Maternal use of B-blockers 5. Maternal diabetes 6. Other conditions where in the opinion of the medical and nursing team the infant requires additional milk to protect the infant’s health

Exclusion criteria

Exclusion criteria: 1. Parents unwilling to accept donated human milk 2. Mother’s not wishing to breastfeed 3. Infant requiring intravenous fluids at birth 4. Inability to randomise within 24 hours of birth

Design outcomes

Primary

MeasureTime frame
Breastfeeding rate measured using electronic medical records at hospital discharge. This outcome is also met if a mother is actively expressing breastmilk which the infant receives wholly or in part via a bottle.

Secondary

MeasureTime frame
Breastfeeding rates and adverse outcomes measured daily using electronic medical records 1. Episodes of hypoglycaemia (Glucose <2.6mmol/L) 2. Adverse outcomes, for example, admission to the neonatal unit 3. Breastfeeding duration (any and exclusive) at discharge and by telephone call at 6 weeks, 3 months post-discharge 4. Use of nasogastric tube feeding or other supplemental feeding methods 5. Length of hospital stay 6. Stools day 0, day 3, 6 weeks corrected age (sent via post) by collection from nappy analysed for: 6.1. Microbiome (16s) 6.2. Calprotectin Trial feasibility outcomes measured monthly using electronic medical and study records: 1. Recruitment rates/eligible infants per month 2. Numbers of infants: 2.1. Recruited before or after delivery 2.2. Recruited during normal working hours 2.3. Receiving non-MOM milk or hypoglycaemic before trial enrolment 3. Numbers of mothers: 3.1. Declining enrolment 3.2. Not returning completed questionnaires 3.3. Unable to contact by telephone post-discharge (lost to follow-up)

Countries

England, United Kingdom

Contacts

Public ContactNicholas Embleton
Nicholas.embleton@ncl.ac.uk+44 (0)191 282 5034

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026